Navigation Links
Sticky surfaces turn slippery with the flip of a molecular light switch

Changing a surface from sticky to slippery could now be as easy as flipping a molecular light switch. Researchers at Rensselaer Polytechnic Institute have created an "optically switchable" material that alters its surface characteristics when exposed to ultraviolet (UV) light. The new material, which is described in the June 19 issue of the journal Angewandte Chemie International Edition, could have a wide variety of applications, from a protein filter for biological mixtures to a tiny valve on a "lab-on-a-chip."

Synthetic polymer membranes are used in a variety of applications based on the science of "bioseparation" -- filtering specific proteins from complex liquid mixtures of biological molecules. But proteins often stick to these membranes, clogging up their pores and severely limiting their performance, according to Georges Belfort, the Russell Sage Professor of Chemical Engineering at Rensselaer and corresponding author of the paper.

"We asked ourselves, can one use light to help the proteins hop on and hop off? We have shown that when one changes light, the proteins don't stick as well," Belfort says.

Operators need an inexpensive way to clean these membranes while they are still in place, rather than periodically removing them from the application environment, Belfort says. But currently the only cleaning options involve expensive chemicals or labor-intensive procedures that result in significant process down-time.

To make the new materials, Belfort and his coworkers attached spiropyran molecules to a widely used industrial polymer, poly(ether sulfone). Spiropyrans are a group of light-switchable organic molecules that exist in a colorless, "closed" form under visible light, but switch to a reddish-purple, "open" form when exposed to UV light. This change leads to an alteration of the new material's polarity, or the chemical structure of its atoms.

In switching from non-polar to polar, the material becomes less attracti
'"/>

Source:Rensselaer Polytechnic Institute


Page: 1 2

Related biology news :

1. Sticky mice lead to discovery of new cause of neurodegenerative disease
2. Shampoo detergent added to paint makes surfaces self-sterilizing
3. Bacteria can survive for weeks on hospital surfaces
4. Researchers to develop active nanoscale surfaces for biological separations
5. Interfering RNA silences genes in slippery immune cells
6. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
7. Source of molecular triggers in cutaneous T cell lymphoma identified
8. Plants, animals share molecular growth mechanisms
9. NYU researchers simulate molecular biological clock
10. Scientists reveal molecular secrets of the malaria parasite
11. Scientists identify molecular events that drive cell senescence
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sticky surfaces turn slippery with the flip molecular light switch

(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/5/2015)... 5, 2015 According to a ... Market by Software, Services, Vertical (BFSI, Airport, IT & Telecom, ... Global Forecast to 2020", published by MarketsandMarkets, defines and ... into various segments. The global PIAM Market is estimated ... Million by 2019, at a CAGR of 14.9 % ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... gone underground to get the most top secret information ... in his experimental orchards, and it is sort of ... is part of a national specialty crop research project ... Texas AgriLife Research horticultural scientist, will focus on pecans ...
... causes temperatures to increase in Hawaii,s mountains, deadly ... the mountains, invading most of the last disease-free ... and remarkable birds. A just-published U.S. ... a forthcoming "disease invasion" by examining the present ...
... around the world will convene at the University of ... from the most ambitious effort ever undertaken to measure ... they contribute in the near term to the dramatic ... two-year international field campaign known as POLARCAT was conducted ...
Cached Biology News:Getting to the root of science in a nutty way 2Jeepers creepers: Climate change threatens endangered honeycreepers 2Jeepers creepers: Climate change threatens endangered honeycreepers 3Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3
(Date:9/2/2015)... , Sep. 02, 2015 ... the addition of Jain PharmaBiotech,s new report "Gene ... offering. The markets for gene therapy are ... gene therapy product and it is marketed in ... are estimated for the years 2014-2024. The estimates are ...
(Date:9/2/2015)... CHARLOTTESVILLE, Virginia , September 2, 2015 ... sponsoring of the winners of the 2015 BeHEARD science ... Institute that offers rare disease researchers, access to the ... will use its drug repositioning and pathway analytics capability ... at Wylder Nation Foundation in the study of Niemann-Pick ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., ... in the multicenter Phase 2 clinical trial of ... treatment of recurrent subfoveal choroidal neovascularization secondary to ... a unique vascular endothelial growth factor (VEGF) receptor ... "This landmark proof-of-concept study will evaluate ...
(Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
Breaking Biology Technology:Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3
... China , May 17 /PRNewswire-Asia-FirstCall/ -- Shengtai,Pharmaceutical, ... and distributor in China of glucose and starch ... that it issued financial results for the third quarter of ... before the opening of the stock,market in USA on ...
... ,, PLEASANTON, Calif. , May 17 TriReme ... for an expanded matrix of sizes for its GliderXtreme™ PTA balloon ... lesions in the peripheral vasculature in balloon diameters from 2.0 – ... , , ...
... ViroPharma Incorporated (Nasdaq: VPHM ) today announced that it ... to prevent attacks of hereditary angioedema (HAE), with West Pharmaceutical Services, ... simple-to-use reconstitution device and accompanying training materials will be widely available ... , , ...
Cached Biology Technology:Shengtai Pharmaceutical Schedules Fiscal Year 2010 Third Quarter Financial Results Conference Call 2Shengtai Pharmaceutical Schedules Fiscal Year 2010 Third Quarter Financial Results Conference Call 3TriReme Medical, Inc. Receives FDA 510(k) Clearance for a Broad Matrix of GliderXtreme(TM) PTA Balloon Catheter Sizes 2ViroPharma Introduces New Reconstitution System for Cinryze™ (C1 Esterase Inhibitor [Human]) 2ViroPharma Introduces New Reconstitution System for Cinryze™ (C1 Esterase Inhibitor [Human]) 3ViroPharma Introduces New Reconstitution System for Cinryze™ (C1 Esterase Inhibitor [Human]) 4ViroPharma Introduces New Reconstitution System for Cinryze™ (C1 Esterase Inhibitor [Human]) 5
V beta 5 Purified Anti-Human clone MH3-2, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
...
... Building on the ease of use and flexibility of ... Biosciences introduces the BDTM LSR II. The BD ... before in a benchtop analyzer. Free up your ... a UV laser to the BD LSR II. The ...
Biology Products: